Umami Bioworks*, a Singapore-based biotechnology company specialising in marine cell cultivation, has expanded its AI-powered platform to produce high-quality, animal-free and scalable marine bioactives. As part of this expansion, Umami Bioworks has also unveiled the world’s first animal-free polydeoxyribonucleotide (PDRN), a rapidly emerging marine ingredient used in skincare, wound healing and regenerative medicine. Umami Bioworks’ proprietary cell biology platform offers a breakthrough alternative: PDRN derived from cultivated marine cell lines under precisely controlled conditions, eliminating the need to transport salmon testicles worldwide and delivering a bioequivalent product. Umami Bioworks is uniquely positioned to serve this need, offering B2B partners a next-generation solution that meets both performance and sustainability standards. *Umami Bioworks is one of Hatch Blue’s portfolio companies, but The Fish Site retains editorial independence.